publication date: Dec. 16, 2016

In Brief Bertagnolli Elected ASCO President

MONICA BERTAGNOLLI was elected president of the American Society of Clinical Oncology for the term beginning in June 2018.

She will take office as president-elect during the ASCO annual meeting in Chicago in June 2017. Additionally, three new members were elected to the ASCO board of directors, as well as two new members to the ASCO nominating committee.

“Serving as ASCO president is a tremendous personal honor for anyone in the field of oncology,” Bertagnolli said in a statement. “Much more importantly, it is an opportunity for me to make a meaningful difference by providing a strong voice in the health care community for those whom I consider to be my particular constituency: clinical and translational researchers, community and academic oncologists participating in clinical research and surgical oncologists.”

Bertagnolli is chief of the Division of Surgical Oncology at Dana-Farber/Brigham and Women’s Cancer Center, a professor of surgery at Harvard Medical School, and an associate surgeon at Brigham and Women’s Hospital and Dana-Farber Cancer Institute. Bertagnolli has served on the ASCO board of directors, the Cancer Prevention Committee, and the Strategic Planning Committee.

She will be the first ASCO President-Elect to serve four years on the ASCO Board (first year as president-elect, second year as president and chair of the board, third year as chair of the … Continue reading Bertagnolli Elected ASCO President

To access this members-only content, please log in.
If you're not a subscriber why not join today?
If you believe you should be able to view this area but cannot log in, then please contact us and we will try to rectify this issue as soon as possible.
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2017 The Cancer Letter Inc.